Low levels of tumor suppressor miR-3619 in plasma contribute to malignant outcomes and a target for nucleic acid therapy in esophageal cancer

Hiroshi Arakawa(Kyoto Prefectural University of Medicine), Eigo Otsuji(Kyoto Prefectural University of Medicine)
Scientific Reports
July 27, 2025
Cited by 1


Related Papers